📰 Accelerate Access News

Accelerate Access News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Accelerate Access. Real-time updates on events, politics, business and more.

UiPath and Google Cloud Expand Strategic Partnership to Accelerate Access to Gen AI and Cloud-based Automation

February 29, 2024

UiPath , a leading enterprise automation and AI software company, and Google Cloud today announced an expanded partnership to extend customers&#039; ability to transform their enterprise with AI-powered automation. UiPath, a Premier Level partner of...

Adaire Fox Martin Google Gmail Kelly Ducourty Foundation Of Innovationtm Product Service Google Cloud Expand Strategic Partnership

Source: lelezard.com

APO Group - Africa Newsroom / Press release | Eastern and Southern African Trade and Development Bank (TDB) and the World Bank to Accelerate Access to Sustainable and Clean Energy in Africa

February 13, 2024

Eastern and Southern African Trade and Development Bank (TDB) and the World Bank to Accelerate Access to Sustainable and Clean Energy in Africa

United States World Bank District Of Columbia Boutheina Guermazi Admassu Tadesse Clean Energy In Africa

Source: africa-newsroom.com

South Africa 'can't afford' to pay for new anti-HIV drug, despite cut-price offer | Global development

November 17, 2023

The jab, given every two months, has been offered on a non-profit basis, but it can’t compete with a cheap daily HIV-prevention pill

Kwazulu Natal South Africa South African Mitchell Warren Khadija Jamaloodien Global Fund

Source: theguardian.com

BHEKISISA | 'Cut the price by three-quarters' says government on anti-HIV jab

November 16, 2023

The health department says ViiV Healthcare’s newly announced non-profit price — between R540 and R570 per shot — for a two-monthly anti-HIV jab is more than four times what it can afford to pay.

South Africa South African Mitchell Warren Enoch Godwongana Khadija Jamaloodien World Health Organisation

Source: timeslive.co.za

How McLean County business, government leaders hope to retain recent growth

July 21, 2023

Recent gains in McLean Countys population and economy have given area economic and government leaders something to celebrate — but also, a puzzle to solve.

United States Oneil Park Gibson City Mclean County Charlie Moore Kevin Mccarthy

Source: pantagraph.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Cipla, Aurobindo, Viatris in licensing pact with MPP to produce generic versions of ViiV Healthcare HIV drug

March 31, 2023

Aurobindo and Viatris will manufacture in India; Cipla will manufacture in India and has plans to manufacture in South Africa as well.

South Africa Philippe Duneton Mitchell Warren Deborah Waterhouse Charles Gore Drug Administration

Source: medicaldialogues.in

UNAIDS welcomes the announcement by Medicines Patent Pool (MPP) and ViiV of three licenses signed with generic manufacturers for long-acting PrEP, and urges further urgent action by ViiV

March 31, 2023

UNAIDS welcomes the announcement by Medicines Patent Pool (MPP) and ViiV of three licenses signed with generic manufacturers Aurobindo, Cipla and Viatris for long-acting Cabotegravir for PrEP (Pre-exposure prophylaxis.) PrEP reduces risk of HIV transmission from sex or injecting drug use. UNAIDS also called for urgent action by ViiV to be taken to reduce the price and increase

South Africa Christine Stegling World Health Organization Coalition To Accelerate Access Long Global Fund Medicines Patent Pool

Source: unaids.org

Merck Provides Update on Phase 3 MOVe-AHEAD Trial Evaluating LAGEVRIO™ (molnupiravir) for Post-expos

February 21, 2023

RAHWAY, N.J.--(BUSINESS WIRE)--$MRK #MRK--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that LAGEVRIO™ (molnupiravir) did not demonstrate a statistically significant reduction in the risk of COVID-19 following household exposure to another individual with COVID-19. The Phase 3...

United States United Kingdom Eastern Cape South Africa Julie Cunningham Deb Wambold

Source: pharmiweb.com

Merck Provides Update on Phase 3 MOVe-AHEAD Trial Evaluating LAGEVRIO (molnupiravir) for Post-exposure Prophylaxis for Prevention of COVID-19

February 21, 2023

21.02.2023 - Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that LAGEVRIO (molnupiravir) did not demonstrate a statistically significant reduction in the risk of COVID-19 following household exposure to another individual ...

United States United Kingdom Eastern Cape South Africa Ridgeback Biotherapeutics Us Department Of Defense

Source: wallstreet-online.de